Prion diseases are neurodegenerative disorders that result from conformational conversion of a normal cell surface glycoprotein (PrP C ) 1 into a pathogenic isoform (PrP Sc ) that appears to be infectious in the absence of nucleic acid (1, 2) . Although a wealth of information is now available about the role of PrP Sc in the disease process, relatively little is known about the normal, physiological function of PrP C . PrP C is expressed in neurons and glia of the brain and spinal cord and at lower levels in several peripheral tissues and in leukocytes (3) (4) (5) (6) (7) . Its localization on the cell surface would be consistent with roles in cell adhesion and recognition, ligand uptake, or transmembrane signaling. Mice in which the endogenous PrP gene has been ablated do not display any gross anatomical or developmental defects (8) but are reported in some studies to have electrophysiological and structural abnormalities in the hippocampus (9 -12) , loss of cerebellar Purkinje cells (13) , or alterations in circadian rhythm and sleep pattern (14) . How these abnormal phenotypes, when present, relate to the normal function of PrP C is unclear. Identifying the function of PrP C may be important in understanding the pathogenesis of prion diseases, because loss of this function as a result of conversion to PrP Sc may explain some features of the disorders. Several new pieces of data suggest that PrP C may play a role in the metabolism of copper. First, the N-terminal half of PrP C contains a series of histidine-and glycine-containing peptide repeats that are capable of binding copper ions. Synthetic peptides or recombinant PrP fragments encompassing the repeats bind copper with a K d of 5-10 M, and binding of the metal induces conformational alterations in the polypeptide chain (15) (16) (17) (18) (19) . Copper also facilitates restoration of protease resistance and infectivity during refolding of guanidine-denatured PrP Sc (20) . Second, the total content of copper but not of several other metals is only 20% of normal in crude membranes, synaptosomes, and endosomes derived from the brains of Prn-p 0/0 mice that contain a disrupted PrP gene (18) . This result suggests that PrP C may be a major copper-binding protein in brain. Third, neuronal Cu-Zn superoxide dismutase (SOD) from Prn-p 0/0 mice is less enzymatically active and incorporates less radioactive copper than the enzyme from normal mice; the opposite is true for SOD from transgenic mice that over-express PrP C (21, 22) . Neurons cultured from Prn-p 0/0 mice are also more sensitive to oxidative insult, perhaps because of reduced SOD activity (21) . These observations raise the possibility that PrP C could be involved in delivery of copper ions to SOD and perhaps other cuproenzymes. Finally, PC12 cells selected for resistance to copper toxicity have increased expression of PrP C , suggesting a role for the protein in removal or detoxification of copper (23) .
Exactly how copper and PrP C are functionally related is unclear at present. One possibility is that bound copper serves as an essential cofactor for an as yet undetermined enzymatic activity of PrP C , as it does in cuproproteins such as SOD and cytochrome c oxidase (24) . By virtue of its presence on the cell surface, PrP C could also function as a sink for chelation of extracellular copper ions or as a carrier protein for uptake and delivery of copper ions to intracellular targets. An important piece of information that may shed light on the functional interaction of PrP C and copper is how the metal affects the cellular localization and trafficking of PrP C . We have shown previously that PrP C is constitutively endocytosed from the plasma membrane via clathrin-coated pits and transits an early endosomal compartment before being recycled back to the cell surface (25) (26) (27) (28) . We report here that copper has a dramatic effect on this cycle.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies-Cell culture reagents were from the Tissue Culture Support Center at Washington University. Phosphatidylinositol-specific phospholipase C (PIPLC) was prepared as described previously (27) . 125 NaI was purchased from Amersham Pharmacia Biotech. All other reagents were from Sigma. Wild-type, ⌬42-65, and ⌬66 -91 chicken PrP (chPrP) were recognized with antiserum F35-96 (29); ⌬25-91 chPrP was recognized with antiserum F144 -220 (29) ; and mouse PrP (moPrP) was recognized with antiserum P45-66 (30) .
Cell Lines-N2a mouse neuroblastoma cells stably transfected to express wild-type moPrP, wild-type chPrP, or N-terminally deleted forms of chPrP (⌬25-91, ⌬42-65, or ⌬66 -91) have been described previously (27) . Cells were maintained in minimal essential media containing 10% fetal calf serum, nonessential amino acids, penicillin/ * This work was supported by Grants AG12925 and AG16462 from the National Institutes of Health (to D. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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Quantitation of Total Cell Surface PrP-Cells were incubated in Opti-MEM (Life Technologies, Inc.) for 90 min at 37°C in the presence or absence of CuSO 4 and were then labeled for 20 min at 4°C using 250 g/ml sulfo-biotin-X-NHS (Calbiochem) in 20 mM HEPES, 150 mM NaCl (pH 7.2). Cell lysates were then subjected to SDS-PAGE, and blots of the gels were probed with horseradish peroxidase-conjugated streptavidin and developed using ECL (Amersham Pharmacia Biotech).
Endocytosis Assays-Internalization of PrP C was measured using surface iodination or biotinylation, as described previously (25, 27) . In the iodination assay, cells were incubated for 20 min on ice with 1 ml of phosphate-buffered saline containing 400 g of glucose, 40 g of lactoperoxidase, 20 g of glucose oxidase, and 100 Ci of 125 NaI. After the reaction was quenched with phosphate-buffered saline containing 1 mM tyrosine and 10 mM sodium metabisulfite, cells were incubated in Opti-MEM at 37°C in the presence or absence of CuSO 4 and were then treated with PIPLC (1 unit/ml in Opti-MEM) at 4°C. PrP was immunoprecipitated from PIPLC incubation media (surface) and cell lysates (internal), analyzed by SDS-PAGE, and quantitated using a Phosphor Imager (Molecular Dynamics).
In the biotinylation assay, cells were labeled for 20 min at 4°C using 250 g/ml sulfo-biotin-X-NHS in 20 mM HEPES, 150 mM NaCl (pH 7.2). After the reaction was quenched with 60 mM glycine in Opti-MEM, the cells were washed extensively with phosphate-buffered saline and were then incubated in Opti-MEM at 37°C in the presence or absence of CuSO 4 for various times. Cells were then treated with PIPLC (1 unit/ml in Opti-MEM) for 2 h at 4°C, and PrP was immunoprecipitated from the PIPLC incubation media and cell lysates. Immunoprecipitates were analyzed by SDS-PAGE, and blots of the gels were probed with horseradish peroxidase-conjugated streptavidin and developed using ECL. Films were digitized using an HP ScanJet II scanner, and the bands were quantitated using SigmaScan/Image (Jandel Scientific).
Reversibility and Recycling Assays-One assay (see Fig. 3 , A and B) was designed to measure readjustment of the steady-state distribution of PrP between the internal and external pools after removal of copper. Surface-iodinated PrP was first allowed to internalize for 20 min at 37°C in the presence of 500 M CuSO 4 . Cells were then washed and incubated a second time at 37°C in Opti-MEM with or without 500 M CuSO 4 for various lengths of time. Surface and internal PrP was scored by PIPLC treatment as described above.
A second assay (see Fig. 3 , C and D) was designed to monitor the recycling of internalized PrP molecules back to the cell surface after removal of copper. Surface-iodinated PrP was allowed to internalize for 20 min in the presence of 500 M CuSO 4 as in the first assay. Surface PrP was then stripped with PIPLC (2 h at 4°C) prior to a second 37°C incubation in Opti-MEM containing PIPLC with or without 500 M CuSO 4 . Cells were then transferred to 4°C and were incubated for a further 2 h to ensure complete removal of surface PrP. PrP was then immunoprecipitated from the medium and cell lysates as above.
RESULTS
We have previously characterized the cellular trafficking of PrP C using lines of N2a mouse neuroblastoma cells that have been stably transfected to express either moPrP or chPrP (29, (25) (26) (27) . We therefore used these cells to examine the effects of copper on the cellular distribution of PrP C . To determine whether copper altered the total amount of PrP C on the cell surface, we treated cells for 90 min with CuSO 4 and then biotinylated them with a membrane-impermeable reagent. The amount of biotinylated PrP was then determined by immunoprecipitating PrP from cell lysates, running the immunoprecipitates on SDS-PAGE, and developing blots of the gel with horseradish peroxidase-streptavidin and ECL. We found that at concentrations of 200 M and above, CuSO 4 dramatically reduced the amounts of both moPrP and chPrP on the cell surface (Fig. 1) . Similar results were obtained when the amount of surface PrP was assayed by sensitivity to externally applied trypsin (data not shown).
Because PrP C in N2a cells is constitutively endocytosed from the plasma membrane (25, 26), we tested whether the effect of copper on the total amount of surface PrP C could be explained by a stimulatory effect on endocytosis. To measure endocytosis, we surface-iodinated cells at 4°C, warmed them to 37°C to initiate internalization, and then scored the amount of iodinated PrP that became inaccessible to externally applied phosphatidylinositol-specific phospholipase C (PIPLC), a bacterial enzyme that cleaves the glycolipid anchor responsible for attaching PrP to the membrane. Using this assay, we found that 500 M CuSO 4 rapidly stimulated internalization of both chPrP (Fig. 2, A and B) and moPrP (not shown). An increase in internalized PrP could be seen after as little as 5 min of incubation, and after 30 min 65% of the protein was internalized, compared with 15% in untreated cells. Stimulation of endocytosis could also be demonstrated using biotinylation rather than iodination to label surface PrP molecules. Using this procedure, the minimum concentration of CuSO 4 required to produce an observable increase in internalization was ϳ100 M (Fig. 2, C and D) . At this concentration, ZnSO 4 also stimulated endocytosis of chPrP, but no effect was seen with CoCl 2 , MnCl 2 , We found that the effect of copper was rapidly reversible. Within 15 min of removal of the metal, PrP began to redistribute from the inside to the outside of the cell, as assayed by accessibility to PIPLC (Fig. 3, A and B) . By 60 min, a new steady-state was reached at which about 40% of the protein was internal, about the same percentage that is reached after endocytosis in the absence of copper (25) . This readjustment of the steady-state distribution is presumably due to the previously documented ability of PrP C molecules to recycle back to surface of N2a cells after they are internalized (25) . To directly measure this recycling process, we first incubated surfaceiodinated cells for 20 min at 37°C in the presence of 500 M CuSO 4 to stimulate internalization of PrP and then stripped surface PrP by treatment with PIPLC at 4°C and finally rewarmed the cells in the presence of PIPLC to release recycled molecules into the medium. Using this procedure (Fig. 3, C and  D) , we found that when copper was absent from the re-warming medium, almost all of the previously internalized PrP recycled to the surface with a t1 ⁄2 of 10 min, consistent with the results of Fig. 3B . Interestingly, when copper was present in the rewarming medium, PrP also returned to the surface, although somewhat more slowly than in the absence of metal (t1 ⁄2 ϭ 20 min). This result implies that although copper markedly stimulates the rate of PrP internalization, it has much less effect on the rate of recycling.
Previous studies have implicated the N-terminal peptide repeats of both mammalian and chicken PrP in copper binding (15, 16, 18, 19) . We have also shown that this region of the polypeptide chain is essential for efficient endocytosis of PrP (27) . We therefore tested the effect of copper on endocytosis of N-terminally deleted forms of chPrP using a surface biotinylation assay (Fig. 4) . chPrP normally contains eight hexapeptide repeats (31) . Deletion of the N-terminal one-third of the molecule (⌬25-91), including all eight hexapeptide repeats, almost completely abolished the effect of copper, although the protein underwent some degradation during the course of the experiment (not shown). Deletion of the first four repeats (⌬42-65) or the last four repeats (⌬66 -91) attenuated but did not eliminate copper-induced internalization of PrP, suggesting that the remaining repeats retain residual copper coordinating activity.
DISCUSSION
Our previous studies have shown that PrP C is constitutively endocytosed from the cell surface via clathrin-coated pits and passes through an early endocytic compartment before being returned to the plasma membrane (29, (25) (26) (27) . We demonstrate here that copper ions rapidly and reversibly stimulate the endocytic arm of this cycle.
It is attractive to speculate that this effect is attributable to binding of copper ions directly to PrP C , because purified, re- At the end of the chase period, cells were treated with PIPLC, and chPrP was immunoprecipitated from PIPLC incubation media (surface, S lanes) and cell lysates (internal, I lanes), followed by analysis by SDS-PAGE and autoradiography. B, the amount of internal PrP was expressed as a percentage of the total amount of PrP (surface ϩ internal) at each chase time. C, the experiment was the same as that described for panel A, except that surface PrP was stripped with PIPLC after the initial 20-min incubation with CuSO 4 , and PIPLC was included in the chase medium during the second 37°C incubation to recover internalized molecules of PrP that returned to the cell surface. D, the amount of internal PrP was expressed as a percentage of the total amount of PrP (surface ϩ internal) at each chase time. The t1 ⁄2 for return of internalized PrP to the cell surface is probably overestimated, particularly in the presence of copper, because PIPLC may not have sufficient time to cleave recycled molecules before they are re-internalized. The experiments shown in this figure are representative of at least three similar ones. combinant forms of PrP have been shown to bind copper ions, most likely via the peptide repeats (15, 16, 18, 19) . Zinc also binds to PrP C , although less tightly than does copper (32). Consistent with a direct effect of copper on the internalization of PrP C , we find that N-terminally deleted forms of chPrP that are missing some or all of the peptide repeats are less efficiently endocytosed than the full-length protein in response to extracellular copper. One hypothesis to explain how binding of copper could stimulate endocytosis of PrP C is that the metal, by altering the conformation of PrP C , increases the affinity of the protein for a putative endocytic receptor that localizes PrP C in clathrin-coated pits. Because PrP C is attached to the cell surface by a glycosyl-phosphatidylinositol anchor, it lacks a cytoplasmic domain that could bind directly to the intracellular components of coated pits. We have therefore postulated the existence of a transmembrane receptor whose extracellular domain binds PrP C via its N-terminal region and whose cytoplasmic domain contains signals for interacting with adapter molecules and clathrin (27, 28) .
Enhanced internalization of PrP C requires copper concentrations in the range of 100 -500 M, which is 10 -50-fold greater than the estimated K d for binding of copper to synthetic PrP peptides and recombinant PrP synthesized in bacteria (15, 16, 18, 19) . This discrepancy may be due, in part, to binding of copper ions to other molecules such as amino acids that are present in the Opti-MEM medium used for our experiments, a phenomenon that would lower the concentration of free copper. It is also possible that the effect of copper on endocytosis occurs by binding to sites on cell-expressed PrP C that are distinct from the ones characterized on bacterially derived or synthetic PrP or to sites on other molecules involved in PrP C internalization. In any case, the average copper concentration in brain has been estimated to be ϳ100 M and may be even higher in specific brain regions (19, 33) . Therefore, the endocytic response we have described here is potentially relevant from a physiological standpoint.
One attractive hypothesis is that PrP C serves as a receptor for uptake of copper ions from the extracellular milieu. PrP C might bind copper ions on the cell surface and then deliver them to an endocytic compartment within which the bound ions dissociate from PrP C and are transferred to other copper-carrier proteins that move the ions into the cytosol. PrP C would then return to the cell surface to begin another cycle. This proposed function for PrP C is analogous to that of the transferrin receptor in uptake of iron (34) , with the exception that the metal ions bind directly to the receptor in the case of PrP C rather than to a protein carrier comparable with transferrin. Although plasma membrane copper transporters and cytoplasmic copper chaperones have been identified in yeast and humans (35) , the molecular mechanism of copper uptake by mammalian cells is still poorly understood (36) . Further exploration of the interaction between PrP C and copper ions at the cellular level may shed important light on this subject.
